Portfolio company
Inventerapharm
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops diagnostic imaging contrast agents for healthcare providers and patients with biliary or pancreatic conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alzeca Biosciences
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
Medical Imaging
This company develops artificial intelligence-powered medical imaging devices and reconstruction software to enhance diagnostic scan quality and efficiency for clinicians and healthcare providers.
NX Pharmagen
This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.
Inventiva
This biopharmaceutical company develops oral small molecule therapies for patients with metabolic dysfunction-associated steatohepatitis and other fibrotic or metabolic diseases.
Adiposs
This biotech company develops medical imaging contrast agents to detect early-stage body wasting for cancer and chronic disease patients.
Rapidscan
This company develops biopharmaceutical stress agents used for cardiovascular disease diagnosis in healthcare settings.
Ictero Medical
This company develops a minimally invasive gallbladder ablation system to treat gallstone disease in patients who wish to avoid traditional surgery.
Blue Earth
This company develops molecular imaging agents and radiopharmaceutical therapies for healthcare professionals to diagnose and treat patients with prostate cancer.
